K-ras ACTIVATION IN RAT RENAL MESENCHYMAL TUMORS INDUCED BY NICKEL SUBSULFIDE
Loading...
Links to Files
Permanent Link
Author/Creator
Author/Creator ORCID
Date
1990-09
Type of Work
Department
Hood College Biology
Program
Biomedical and Environmental Science
Citation of Original Publication
Rights
Subjects
Abstract
Renal mesenchymal tumors were induced in high incidence in male F344 rats by a single intrarenal injection of nickel subsulfide (Ni₃S₂) alone or nickel subsulfide plus iron (Fe°) or magnesium carbonate (MgCarb) (Kasprzak et al., 1990a). The tumors appeared by light microscopy to be comparable in histogenesis to the renal mesenchymal tumors induced by nitrosamines including methyl(methoxymethyl)nitrosamine (DMN-0Me) but were more pleomorphic and had a distinct tendency to metastasize. High-molecular-weight DNA was prepared from the tumors and assayed for transforming activity in NIH 3T3 cells; DNAs from 4 of 16 tumors showed transforming activity. Southern analysis confirmed the presence of the rat K-ras oncogene in the transformed NIH 3T3 clone derived from one of the mesenchymal tumors. Selective oligonucleotide hybridization analysis of polymerase chain reaction (PCR) amplified K-ras gene sequences revealed that 7 of 9 primary tumors induced with N1₃S₂ and Fe° and 1 of 13 primary tumors induced with Ni₃S₂ alone contained exclusively GGT - GTT activating mutations in codon 12. A GGT -. GAT transition was identified in one
passaged tumor which had originally contained a GGT - GTT transversion in the primary tumor. The presence of those activating codon 12 point mutations was confirmed by direct sequencing of the PCR amplified K-ras sequences. Sequencing also revealed that there were no other activating mutations at the other codons, 13 and 59-61, that result in activation of the c-K-ras proto-oncogene. These results show that in the rat kidney, Ni₃S₂ carcinogenesis is associated with site-specific activation of a specific cellular proto-oncogene in a fashion consistent with direct interaction of the carcinogen with cellular DNA encoding the target proto-oncogene.